CompanyDrug

Roche’s Tecentriq in Combination with Exelixis’s Cabometyx Meets Primary Endpoint in mCRPC Phase III Study

CompanyDrug

Pfizer’s Nurtec Approved by China’s NMPA for Acute Treatment of Migraines

CompanyDrug

Novo Nordisk’s Rybelsus Approved for Type 2 Diabetes in China, Setting New Oral Treatment Standard

Company

BJ Bioscience Inc. Faces Bankruptcy as Hangzhou Court Accepts Liquidation Application

Company

Wantai Biological Forecasts Sharp Drop in 2023 Net Profits Amid HPV Vaccine Sales Slump

CompanyDrug

Eli Lilly’s Subsidiary Akouos Reports Positive Preliminary Results for Gene Therapy in Hearing Loss

CompanyDeals

Shanghai Pharmaceuticals and HKSTPC Launch 01LABS@Hong Kong Incubator

CompanyDrug

Biosion’s SIRPα-Targeting Monoclonal Antibody BSI-082 Clears US FDA Clinical Trial Hurdle

CompanyDrug

IASO Biotherapeutics Secures NMPA Approval for Fucaso in Refractory Myasthenia Gravis

CompanyDrug

MSD’s Keytruda Combines with PharmAbcine’s PMC-309 in Phase Ia/b Solid Tumor Trial

Policy / Regulatory

NMPA Proposes Streamlined Market Approval Process for Domestically Produced Overseas Drugs

CompanyDeals

GSK In-Licenses Elegen’s Cell-Free DNA Tech to Advance Next-Gen Gene Therapies and Vaccines